课题基金 / 基金详情

A novel mechanism of chemoresistance in ovarian cancer cells

A novel mechanism of chemoresistance in ovarian cancer cells
卵巢癌细胞化疗耐药的新机制
批准号：
343969
负责人：
Drobetsky Elliot A
金额：
$41.21万
依托单位：
Centre de recherche de l'Hôpital Maisonneuve-Rosemont (Montral)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-03-01 至 2020-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=343969&lang=en
关键词：
Cell Cycle Chemoresistance Dna Repair Flow Cytometry Ovarian Cancer Replicative Stress Response

项目摘要

项目成果

Drobetsky Elliot A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
According to the Canadian Cancer Society, this past year 2800 Canadian women were diagnosed with ovarian cancer and 1750 succumbed to this deadly disease. Chemotherapeutic drugs used to treat ovarian cancer can be initially very effective, even restoring
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Replicative stress as a primary determinant of chemotherapeutic outcome in ovarian cancer
Regulation of UV Damage Repair by the ATR-mediated DNA Damage Checkpoint in Malignant Melanoma
海外基金